AIG
KPTI icon

American International Group’s Karyopharm Therapeutics KPTI Stock Holding History

American International Group’s Portfolio KPTI Stock Details KPTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-3,721
Closed -$84.3K – 1430
2024
Q1 		$84.3K Sell
3,721
-32
-0.9% -$561 ﹤0.01% 2609
2023
Q4 		$48.7K Sell
3,753
-15
-0.4% -$202 ﹤0.01% 2822
2023
Q3 		$75.7K Buy
3,768
+134
+4% +$3.01K ﹤0.01% 2663
2023
Q2 		$97.6K Buy
3,634
+1,129
+45% +$48.6K ﹤0.01% 2590
2023
Q1 		$146K Buy
2,505
+50
+2% +$2.47K ﹤0.01% 2291
2022
Q4 		$125K Buy
2,455
+44
+2% +$3.05K ﹤0.01% 2402
2022
Q3 		$197K Buy
2,411
+34
+1% +$2.54K ﹤0.01% 2164
2022
Q2 		$161K Sell
2,377
-6
-0.3% -$550 ﹤0.01% 2327
2022
Q1 		$263K Sell
2,383
-168
-7% -$20.9K ﹤0.01% 2084
2021
Q4 		$246K Sell
2,551
-76
-3% -$7.58K ﹤0.01% 2250
2021
Q3 		$229K Sell
2,627
-62
-2% -$6.44K ﹤0.01% 2356
2021
Q2 		$416 Sell
2,689
-65
-2% -$9.43K ﹤0.01% 2042
2021
Q1 		$435 Buy
2,754
+37
+1% +$7.8K ﹤0.01% 1910
2020
Q4 		$631 Sell
2,717
-78
-3% -$18.1K ﹤0.01% 1629
2020
Q3 		$612K Sell
2,795
-64
-2% -$15.7K ﹤0.01% 1491
2020
Q2 		$812K Buy
2,859
+508
+22% +$150K ﹤0.01% 1332
2020
Q1 		$678K Sell
2,351
-136
-5% -$37.5K ﹤0.01% 1286
2019
Q4 		$715K Buy
2,487
+13
+0.5% +$2.82K ﹤0.01% 1505
2019
Q3 		$357K Buy
2,474
+26
+1% +$3.52K ﹤0.01% 1834
2019
Q2 		$220K Buy
2,448
+360
+17% +$28.9K ﹤0.01% 2165
2019
Q1 		$183K Sell
2,088
-40
-2% -$4.43K ﹤0.01% 2258
2018
Q4 		$299K Sell
2,128
-16
-0.7% -$2.7K ﹤0.01% 1952
2018
Q3 		$548K Buy
2,144
+39
+2% +$10.8K ﹤0.01% 1835
2018
Q2 		$537K Buy
2,105
+591
+39% +$146K ﹤0.01% 1786
2018
Q1 		$305K Sell
1,514
-4
-0.3% -$798 ﹤0.01% 2011
2017
Q4 		$219K Buy
1,518
+7
+0.5% +$1.12K ﹤0.01% 2265
2017
Q3 		$249K Buy
1,511
+113
+8% +$16.2K ﹤0.01% 2163
2017
Q2 		$190K Buy
1,398
+303
+28% +$44.8K ﹤0.01% 2299
2017
Q1 		$211K Buy
1,095
+189
+21% +$30.3K ﹤0.01% 2155
2016
Q4 		$128K Sell
906
-2
-0.2% -$270 ﹤0.01% 2457
2016
Q3 		$133K Buy
908
+1
+0.1% +$120 ﹤0.01% 2443
2016
Q2 		$91.3K Sell
907
-28
-3% -$3.64K ﹤0.01% 2677
2016
Q1 		$125K Sell
935
-17
-2% -$1.88K ﹤0.01% 3230
2015
Q4 		$189K Buy
952
+15
+2% +$3.25K ﹤0.01% 2901
2015
Q3 		$148K Buy
937
+1
+0.1% +$267 ﹤0.01% 3100
2015
Q2 		$382K Buy
936
+367
+64% +$159K ﹤0.01% 2428
2015
Q1 		$261K Hold
569
– – ﹤0.01% 2718
2014
Q4 		$319K Buy
569
+28
+5% +$15.9K ﹤0.01% 2537
2014
Q3 		$283K Buy
541
+1
+0.2% +$564 ﹤0.01% 2631
2014
Q2 		$377K Buy
540
+185
+52% +$86.1K ﹤0.01% 2416
2014
Q1 		$164K Buy
355
+9
+3% +$4.56K ﹤0.01% 3012
2013
Q4 		$119K Buy
+346
New +$95.6K ﹤0.01% 3221

Other funds holding KPTI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

American International Group's KPTI Position: Q2 2024 in Review

American International Group sold out of Karyopharm Therapeutics (KPTI) in Q2 2024, closing a stake of 3,721 shares — an estimated $84.3K sold.

American International Group first reported a position in KPTI in Q4 2013 and held it in 42 quarters. The position peaked at $812K in Q2 2020. 114 funds tracked by Wall St. Rank hold KPTI as of Q2 2024.

  • American International Group reported no remaining Karyopharm Therapeutics position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 3,721 Karyopharm Therapeutics shares in Q2 2024, an estimated $84.3K.
  • American International Group first reported a position in Karyopharm Therapeutics in Q4 2013 and held it in 42 quarters.
  • American International Group's Karyopharm Therapeutics position peaked at $812K in Q2 2020.
  • 114 funds tracked by Wall St. Rank held Karyopharm Therapeutics as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.